Sigma Healthcare Limited announced that against a backdrop of entering the final stage of investment cycle, progressively stabilising and optimising operations, and a strategic review of the business, Sigma is not providing specific guidance for 2023 at this stage, but expects to return to profit.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.175 AUD | -0.42% | -6.37% | +16.92% |
30/05 | Transcript : Sigma Healthcare Limited - Shareholder/Analyst Call | |
10/05 | Sigma Healthcare Limited(ASX:SIG) added to S&P/ASX 200 Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.92% | 121.49Cr | |
+26.77% | 7.63TCr | |
-2.27% | 2.4TCr | |
+10.27% | 900.83Cr | |
+12.25% | 866.97Cr | |
-24.34% | 757.62Cr | |
+12.70% | 517.56Cr | |
+2.89% | 416.19Cr | |
-4.96% | 398.33Cr | |
-1.36% | 363.3Cr |
- Stock Market
- Equities
- SIG Stock
- News Sigma Healthcare Limited
- Sigma Healthcare Limited Provides Earnings Guidance for the Year 2023